Annual SGA
$45.94 M
+$3.04 M+7.09%
November 30, 2024
Summary
- As of February 8, 2025, NRIX annual SGA is $45.94 million, with the most recent change of +$3.04 million (+7.09%) on November 30, 2024.
- During the last 3 years, NRIX annual SGA has risen by +$14.74 million (+47.25%).
- NRIX annual SGA is now at all-time high.
Performance
NRIX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$10.72 M
-$1.00 M-8.54%
November 30, 2024
Summary
- As of February 8, 2025, NRIX quarterly SGA is $10.72 million, with the most recent change of -$1.00 million (-8.54%) on November 30, 2024.
- Over the past year, NRIX quarterly SGA has dropped by -$1.08 million (-9.17%).
- NRIX quarterly SGA is now -9.17% below its all-time high of $11.80 million, reached on February 29, 2024.
Performance
NRIX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.64 B
-$193.57 M-7.92%
November 30, 2024
Summary
- As of February 8, 2025, NRIX TTM SGA is -$2.64 billion, with the most recent change of -$193.57 million (-7.92%) on November 30, 2024.
- Over the past year, NRIX TTM SGA has dropped by -$2.68 billion (-5975.60%).
- NRIX TTM SGA is now -4261.80% below its all-time high of -$60.46 million.
Performance
NRIX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NRIX Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +7.1% | -9.2% | -5975.6% |
3 y3 years | +47.3% | +9.1% | -6933.3% |
5 y5 years | +451.8% | +9.1% | -6933.3% |
NRIX Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +47.3% | -9.2% | +21.5% | -284.2% | at low |
5 y | 5-year | at high | +451.8% | -9.2% | +337.4% | -4261.8% | at low |
alltime | all time | at high | +588.4% | -9.2% | +390.7% | -4261.8% | at low |
Nurix Therapeutics Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Nov 2024 | $45.94 M(+7.1%) | $10.72 M(-8.5%) | $45.94 M(-0.1%) |
Aug 2024 | - | $11.72 M(+0.1%) | $46.01 M(+2.4%) |
May 2024 | - | $11.71 M(-0.8%) | $44.91 M(+0.1%) |
Feb 2024 | - | $11.80 M(+9.5%) | $44.88 M(+4.6%) |
Nov 2023 | $42.90 M(+12.9%) | $10.78 M(+1.5%) | $42.90 M(+3.4%) |
Aug 2023 | - | $10.62 M(-9.0%) | $41.49 M(+2.2%) |
May 2023 | - | $11.68 M(+18.9%) | $40.61 M(+5.2%) |
Feb 2023 | - | $9.82 M(+4.8%) | $38.59 M(+1.6%) |
Nov 2022 | $38.00 M | $9.37 M(-3.9%) | $38.00 M(+1.5%) |
Aug 2022 | - | $9.75 M(+1.0%) | $37.45 M(+3.9%) |
May 2022 | - | $9.65 M(+4.6%) | $36.04 M(+6.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Feb 2022 | - | $9.23 M(+4.6%) | $33.90 M(+8.6%) |
Nov 2021 | $31.20 M(+91.3%) | $8.82 M(+5.7%) | $31.20 M(+9.0%) |
Aug 2021 | - | $8.34 M(+11.1%) | $28.64 M(+16.3%) |
May 2021 | - | $7.51 M(+15.0%) | $24.63 M(+20.8%) |
Feb 2021 | - | $6.53 M(+4.4%) | $20.39 M(+25.0%) |
Nov 2020 | $16.31 M(+95.9%) | $6.25 M(+44.1%) | $16.31 M(+28.8%) |
Aug 2020 | - | $4.34 M(+32.7%) | $12.66 M(+20.5%) |
May 2020 | - | $3.27 M(+33.5%) | $10.51 M(+45.2%) |
Feb 2020 | - | $2.45 M(-5.8%) | $7.24 M(+51.2%) |
Nov 2019 | $8.33 M(+24.8%) | $2.60 M(+19.1%) | $4.79 M(+119.1%) |
Aug 2019 | - | $2.18 M | $2.18 M |
Nov 2018 | $6.67 M | - | - |
FAQ
- What is Nurix Therapeutics annual SGA?
- What is the all time high annual SGA for Nurix Therapeutics?
- What is Nurix Therapeutics annual SGA year-on-year change?
- What is Nurix Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly SGA year-on-year change?
- What is Nurix Therapeutics TTM SGA?
- What is the all time high TTM SGA for Nurix Therapeutics?
- What is Nurix Therapeutics TTM SGA year-on-year change?
What is Nurix Therapeutics annual SGA?
The current annual SGA of NRIX is $45.94 M
What is the all time high annual SGA for Nurix Therapeutics?
Nurix Therapeutics all-time high annual SGA is $45.94 M
What is Nurix Therapeutics annual SGA year-on-year change?
Over the past year, NRIX annual SGA has changed by +$3.04 M (+7.09%)
What is Nurix Therapeutics quarterly SGA?
The current quarterly SGA of NRIX is $10.72 M
What is the all time high quarterly SGA for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly SGA is $11.80 M
What is Nurix Therapeutics quarterly SGA year-on-year change?
Over the past year, NRIX quarterly SGA has changed by -$1.08 M (-9.17%)
What is Nurix Therapeutics TTM SGA?
The current TTM SGA of NRIX is -$2.64 B
What is the all time high TTM SGA for Nurix Therapeutics?
Nurix Therapeutics all-time high TTM SGA is -$60.46 M
What is Nurix Therapeutics TTM SGA year-on-year change?
Over the past year, NRIX TTM SGA has changed by -$2.68 B (-5975.60%)